Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening

Published:2019-01-28 Issue:1 Volume:13 Page:e0007126
ISSN:1935-2735
Container-title:PLOS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

Arenaz-Callao María Pilar,González del Río Rubén,Lucía Quintana Ainhoa,Thompson Charles J.^ORCID,Mendoza-Losana Alfonso,Ramón-García Santiago^ORCID

Funder

Tres Cantos Open Lab Foundation

FP7 People: Marie-Curie Actions

H2020 RIA actions

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference70 articles.

1. Tackling the worsening epidemic of Buruli ulcer in Australia in an information void: time for an urgent scientific response;DP O'Brien;Med J Aust,2018

2. World Health Organization. Treatment of Mycobacterium ulcerans disease (Buruli ulcer). Guidance For Health Workers. Geneva. 2012.

3. Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease;J. Guarner;J Clin Microbiol,2018

4. A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine;WD Revill;Lancet,1973

5. A pilot study of treatment of Buruli ulcer with rifampin and dapsone;DK Espey;Int J Infect Dis,2002

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of extended-release clarithromycin in patients with Mycobacterium ulcerans infection;Scientific Reports;2024-08-28

2. Amoxicillin/clavulanate in combination with rifampicin/clarithromycin is bactericidal against Mycobacterium ulcerans;PLOS Neglected Tropical Diseases;2024-04-04

3. In vitro synergy screens of FDA-approved drugs reveal novel zidovudine- and azithromycin-based combinations with last-line antibiotics against Klebsiella pneumoniae;Scientific Reports;2023-09-02

4. Recent Advances in the Management Strategies for Buruli Ulcers;Pathogens;2023-08-27

5. Mutations in rpoB That Confer Rifampicin Resistance Can Alter Levels of Peptidoglycan Precursors and Affect β-Lactam Susceptibility;mBio;2023-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3